OssDsign: First PROPEL data looks strong - Redeye

Return gives its insights on the recently published PROPEL data. We are encouraged by the increasing clinical documentation and make minor positive revisions to our long-term estimates, resulting in an increased fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1116318/ossdsign-first-propel-data-looks-strong?utm_source=finwire&utm_medium=RSS